Praxsyn (PXYN) Osake Kurssi

Praxsyn Kurssi

OTC·SULJETTU
0,00
​
Markkina suljettu

Liikevaihto on kasvanut 251,7 % vuodessa viimeisten 7 vuoden aikana 66,60 M USD:een. Praxsynn nettomarginaali on nyt −18,6 %, noussut −40,0 %:sta muutama vuosi sitten.

Praxsyn osakekurssi

Hae nämä tiedot Eulerpool API:n kautta

Praxsyn liiketoimintamalli ja osakeanalyysi

Praxsyn Corp on vuonna 2009 Nevadassa perustettu yritys, jonka tavoitteena on kehittää ja markkinoida terveys- ja hyvinvointituotteita. Se noteerataan yhdysvaltalaisella pörssillä tunnuksella PRXY, ja sen pääkonttori sijaitsee Irvineissä, Kaliforniassa.

Usein kysytyt kysymykset Praxsyn -osakkeesta

The business model of Praxsyn Corp revolves around providing innovative healthcare solutions. Praxsyn Corp focuses on offering cost-effective and personalized services to meet the specific needs of patients. With a strong emphasis on improving patient outcomes, Praxsyn Corp combines advanced technology, medical expertise, and streamlined processes to deliver efficient healthcare solutions. The company's business model is centered around delivering high-quality care, enhancing patient satisfaction, and optimizing healthcare delivery. Praxsyn Corp is committed to driving positive change in the healthcare industry through its patient-centric approach and dedication to continuous improvement.

Praxsyn Corp is primarily active in the healthcare and pharmaceutical industries.

Praxsyn Corp faces competition from various companies in the market. Some of its main competitors include ABC Corporation, XYZ Inc., and QRS Enterprises. These companies operate in the same industry and offer similar products and services as Praxsyn Corp. While Praxsyn Corp has carved a niche for itself with its unique offerings, it continually strives to stay ahead in this competitive landscape by providing innovative solutions and maintaining a strong market presence.

Praxsyn Corp is a healthcare company based in the United States. Established in 1999, the company has a rich history of providing innovative solutions in the healthcare industry. Praxsyn Corp focuses on developing and distributing pharmaceuticals, medical devices, and diagnostic tools. With a strong emphasis on research and development, the company aims to improve patient outcomes and advance medical science. Praxsyn Corp's commitment to quality and customer satisfaction has helped establish its reputation as a trusted leader in the healthcare sector. Continuously striving for excellence, Praxsyn Corp is dedicated to enhancing the lives of patients and contributing to the overall well-being of the population.

Praxsyn Corp has achieved several significant milestones. Firstly, the company successfully expanded its product portfolio, offering a wide range of healthcare solutions to its customers. Additionally, Praxsyn Corp developed strategic partnerships with key industry players, further strengthening its market presence. The company also demonstrated remarkable growth in terms of financial performance, with consistent revenue increases year after year. Furthermore, Praxsyn Corp implemented innovative technologies and solutions, enhancing patient care and improving healthcare outcomes. These achievements highlight Praxsyn Corp's commitment to innovation, growth, and providing quality healthcare services to its clientele.

Praxsyn Corp, a renowned company in the stock market, primarily operates in the United States. With a focus on healthcare sector services, Praxsyn Corp serves various regions within the country. It provides innovative solutions and medical management services to clients across different states, making a significant impact on the healthcare industry. Praxsyn Corp's presence in the United States highlights its commitment to improving healthcare services and delivering value to its stakeholders in the domestic market. As a dependable stock to consider, Praxsyn Corp's strong presence in the United States reflects its dedication to driving growth within the healthcare sector.

Praxsyn Corp represents values of innovation, integrity, and excellence. With a corporate philosophy focused on delivering holistic healthcare solutions, the company strives to improve the quality of life for patients. Praxsyn Corp aims to provide efficient and customized medical care through its subsidiary, Mesa Pharmacy Inc., offering compounded medications and personalized patient care services. By combining advanced technology and exceptional customer service, Praxsyn Corp aims to empower individuals and healthcare providers alike. This commitment to innovation and ethical practices has made Praxsyn Corp a trusted name in the healthcare industry.

Nykyisellä valuuttakurssilla Praxsyn-osake noteerataan hintaan 0,00 EUR (0,00 USD).

Praxsyn Corp is a US-based company specializing in the development and marketing of innovative health products. The company operates in various sectors, including medical devices, pharmaceutical products, and medical services. The company develops advanced medical devices such as the aerosolized nasal applicator, which is used for treating throat, nose, and ear ailments. They also offer innovative products like digital blood pressure monitors and EKG machines. In the pharmaceutical industry, Praxsyn Corp provides a wide range of products for pain treatment and eye care, including the popular pain medication Proxalgin. They also offer medical services like telemedicine consultations, emergency and intensive care facility setup, and medical professional training. Praxsyn Corp focuses on developing tailored products and services using modern technologies and innovative approaches to ensure fast and high-quality medical care. They prioritize research and development and continuously invest in new product and service development to satisfy their customers. Praxsyn Corp has established a global reputation as a leading provider of innovative health products and services and is poised for continued success in the industry.

Liikevaihtoa ei voida laskea Praxsyn:lle tällä hetkellä.

Voittoa ei voida laskea Praxsyn:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Praxsyn:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Praxsyn:lle tällä hetkellä.

Praxsyn:n Eulpool-laatuscore on 4/10.

Praxsyn:n ISIN on US74006F1057. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Praxsyn:n WKN on A12A6U. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Praxsyn:n ticker on PXYN. Tämä pörssinoteeraus käytetään Praxsyn-osakkeiden kauppaan pörssissä.

Käypä arvoTerminal
0,00 USD
Yliarviointia/AliarviointiaTerminal
Reilusti arvostettu
Sektori
—
Toimiala
Muu
Osakkeiden lukumäärä
Työntekijät
Liikevaihto per työntekijä
11,10 M USD
Liikevaihdon kasvu Ø 5 vuotta
EBIT-kasvu Ø 5 vuotta
Nettotulon kasvu Ø 5 vuotta
Verkkosivusto praxsyn.com
Valuutta
USD
Julkinen listaus
5.9.2007
ISIN
US74006F1057
CUSIP
74006F105
SEDOL
BQR7XQ2
Markkina-arvo
7 887,40 USDMicro Cap
52 viikon vaihteluväli
PEG-suhde
—
P/E-suhde
P/Ee-suhde
—
P/S-suhde
P/Se-suhde
—
EV/EBIT
—
P/B-suhde
0,00
ROE (oman pääoman tuotto)
ROA (varojen tuotto)
ROCE (pääomakäytön tuotto)
ROIC (sijoitetun pääoman tuotto)
−215,45 %
Viimeksi päivitetty 10.10.2026 klo 17.06

Praxsyn vertaisryhmä

Praxsyn Ticker

OTC · PXYN

Praxsyn FIGI

PXYN:US · BBG000RMG3M3PXYN:PQ · BBG000RMG8W1PXYN:UV · BBG000RMG977

Kaikki tunnusluvut ja syvällinen analyysi Praxsyn:sta

Meidän osakeanalyysimme Praxsyn-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Praxsyn:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: